- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | CDC panel votes to revoke newborn hepatitis B vaccine recommendation | ||
| Fr | Crescent and Kelun-Biotech swap cancer asset rights in double deal | ||
| Fr | Denali makes $275m funding agreement with Royalty Pharma | ||
| Fr | Takeda and Innovent fulfil close conditions for ADC and IO therapies | ||
| Do | Former FDA commissioners unite to condemn US vaccine proposals | ||
| Do | FDA appoints Tracy Beth Høeg as fifth CDER head this year | ||
| Do | Formosa and Rxilient sign licensing agreement for APP13007 | ||
| Do | FDA approves Eli Lilly's Jaypirca in relapsed or refractory CLL/SLL | ||
| Mi | Richard Padzur to leave FDA following recent CDER leadership shift | ||
| Mi | AGC Biologics to expand cell line development with ATUM partnership | ||
| Mi | Citizen Health and UCB collaborate for epilepsy drug development | ||
| Di | FDA steps back from preclinical primate testing amid wider regulatory shift | ||
| Di | WHO backs use of GLP-1RAs for weight loss despite shortage warning | ||
| Di | House passes bill that reauthorises the FDA's paediatric priority voucher pathway | ||
| Di | Solid Biosciences' SGT-212 gains FDA rare paediatric disease status | ||
| Di | Lotus submits NDA for VIZZ in South Korea to treat presbyopia | ||
| Mo | UK and US strike "landmark" zero-tariff pharma deal | ||
| Mo | Regeneron and Tessera join forces to forge in vivo AATD gene therapy | ||
| Mo | "Sharp" funding cuts disrupt PrEP access to millions of HIV patients | ||
| Mo | Eisai seeks PMDA approval for subcutaneous Leqembi in Japan | ||
| Mo | US FDA approves Lupin's Armlupeg injection | ||
| 28.11. | WHO warns of immunisation strategy gaps amid measles outbreaks | ||
| 28.11. | Celltrion secures Health Canada go-ahead for Eylea biosimilar | ||
| 28.11. | Over half of European HIV patients diagnosed late, ECDC report finds | ||
| 28.11. | IASO Bio gains Hong Kong approval for Fucaso application |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .